ERBB2 and TOP2A in breast cancer: a comprehensive analysis of gene amplification, RNA levels, and protein expression and their influence on prognosis and prediction. [electronic resource]
Producer: 20100812Description: 2391-401 p. digitalISSN:- 1557-3265
- Antigens, Neoplasm -- genetics
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor -- genetics
- Breast Neoplasms -- drug therapy
- Chemotherapy, Adjuvant
- Cohort Studies
- Cyclophosphamide -- administration & dosage
- DNA Topoisomerases, Type II -- genetics
- DNA-Binding Proteins -- genetics
- Epirubicin -- administration & dosage
- Female
- Gene Amplification
- Humans
- Immunoenzyme Techniques
- In Situ Hybridization, Fluorescence
- Middle Aged
- Neoadjuvant Therapy
- Neoplasm Proteins -- metabolism
- Neoplasm Staging
- Pilot Projects
- Poly-ADP-Ribose Binding Proteins
- RNA, Neoplasm -- genetics
- Receptor, ErbB-2 -- genetics
- Receptors, Estrogen -- metabolism
- Survival Rate
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.